Open Access

Cardiac and plasma lipid profiles in response to acute hypoxia in neonatal and young adult rats

Lipids in Health and Disease20109:3

https://doi.org/10.1186/1476-511X-9-3

Received: 17 November 2009

Accepted: 13 January 2010

Published: 13 January 2010

Abstract

Background

The physiological and biochemical responses to acute hypoxia have not been fully characterized in neonates. Fatty acids and lipids play an important role in most aspects of cardiac function.

Methods

We performed comprehensive lipid profiling analysis to survey the changes that occur in heart tissue and plasma of neonatal and young adult rats exposed to hypoxia for 2 h, and following 2 h of recovery from hypoxia.

Results

Cardiac and plasma concentrations of short-chain acylcarnitines, and most plasma long-chain fatty acids, were decreased in hypoxic neonates. Following recovery from hypoxia, concentrations of propionylcarnitine, palmitoylcarnitine, stearoylcarnitine were increased in neonatal hearts, while oleylcarnitine and linoleylcarnitine concentrations were increased in neonatal plasma. The concentrations of long-chain fatty acids and long-chain acylcarnitines were increased in the hearts and plasma of hypoxic young adult rats; these metabolites returned to baseline values following recovery from hypoxia.

Conclusion

There are differential effects of acute hypoxia on cardiac and plasma lipid profiles with maturation from the neonate to the young adult rat. Changes to neonatal cardiac and plasma lipid profiles during hypoxia likely allowed for greater metabolic and physiologic flexibility and increased chances for survival. Persistent alterations in the neonatal cardiac lipid profile following recovery from hypoxia may play a role in the development of rhythm disturbances.

Background

Pulmonary and cardiac dysfunction results in hypoxemia in neonates that, in turn, may lead to hypothermia and bradycardia [15]. Myocardial lipid composition affects electrophysiological and mechanical function due to modulation of the physicochemical properties of cellular membranes [611]. Fatty acids also generate a constant supply of ATP needed for normal myocardial function [12]. Perturbations in cardiac fatty acid composition may lead to defects in ion channel function, decreases in mitochondrial oxidative capacity, and rhythm disturbances [1316].

The present study evaluated cardiac and plasma lipid, fatty acid, and acylcarnitine profiles in response to and after recovery from severe hypoxia in neonatal (PD2) and young adult (PD60) rats. We identified hypoxia-induced changes in cardiac and plasma lipid profiles that may be important in cardiac function, either during or recovery from hypoxia.

Methods

The Aurora Health Care IACUC approved the animal protocol. Timed-pregnant Sprague-Dawley rats at gestational day 15 (N = 6) and male rats at postnatal day (PD) 50 (175-200 g; N = 12) from Harlan Sprague Dawley (Indianapolis, IN) were maintained on a standard diet and water ad libitum in a controlled environment (0600-1800 lights on). The size of litters was normalized (12 pups/litter; N = 72 pups). PD2 pups were placed in chambers and allowed to nest and huddle on an adequate amount of bedding. After 30 min of room air (8 L/min), 3-4 pups from each litter were removed from the chamber, sacrificed, and baseline samples pooled. Then, the input O2 concentration was decreased to 8%. After 2 h, 3-4 pups from each litter were removed from the chamber, sacrificed, and samples pooled; the O2 concentration in each chamber was then returned to 21%. Remaining pups were sacrificed following a 2 h recovery period. PD60 rats were similarly exposed to hypoxia (3 rats per chamber).

Rats were sacrificed by decapitation and trunk blood was collected into EDTA. Blood samples were centrifuged for 10 sec (within 10 sec of collection) in a microfuge at room temperature with plasma frozen immediately. Plasma samples from PD2 pups were pooled (4 pups/sample). Whole hearts from PD2 rats were immediately excised, rinsed in ice-cold saline, and frozen in liquid nitrogen (3 @ PD2 hearts per sample). Plasma and hearts from each PD60 rat was treated as one sample (N = 4 sacrificed per time point).

A comprehensive assessment of heart and plasma lipid profiles was performed (Lipomics Technologies, Inc., West Sacramento, CA) as described previously [17]. Intra-assay CVs were: cholesterol ester (CE; 2.0%), diacylglyercol (DAG; 5.5%), free fatty acid (FFA; 3.5%), lysophosphatidylcholine (LPC; 12.2%), phosphatidylcholine (PC; 5.0%), phosphatidylethanolamine (PE; 13.0%), phosphatidylserine (PS; 10.0%) and triacylglycerol (TAG; 0.4%). Samples for acylcarnitine profiling were prepared for liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis in the presence of dueterated surrogates for quantitation through a modified liquid preparation and injected onto an 1100 Series HPLC (Agilent Technologies, CA) connected to a Quattro Premier triple quadrupole mass spectrometer (Waters, MA). The analytes were ionized via positive electrospray and the mass spectrometer was operated in the tandem MS mode.

Data are expressed as mean ± SEM. Significant differences were assessed by one-way ANOVA with post hoc Student-Newman-Keuls analysis for multiple comparisons (SigmaStat 2.03). Differences in baseline lipid class concentrations (PD2 vs. PD60) were assessed by unpaired Student's t-test.

Results

Hearts from PD60 rats had higher baseline FFA, PC, and PE when compared to hearts from PD2 rats (Table 1). Plasma from PD60 rats had significantly higher CE at baseline, while DAG, PC, PE, and TAG were lower compared to plasma from PD2 rats.
Table 1

Baseline lipid class concentrations (nmol/g) in the heart and plasma of PD2 and PD60 rats - effects of age.

Lipid Class

Source

PD2

PD60

P Value

Cholesterol Ester (CE)

Heart

337.75 ± 96.09

424.50 ± 102.75

0.560

 

Plasma

1249.00 ± 41.23

1449.00 ± 48.61*

0.020

Diacylglycerol (DAG)

Heart

293.75 ± 30.56

334.00 ± 13.10

0.272

 

Plasma

65.75 ± 8.84

30.00 ± 7.22*

0.020

Free Fatty Acid (FFA)

Heart

1230.00 ± 113.48

2093.50 ± 153.14*

0.004

 

Plasma

689.25 ± 53.22

653.00 ± 27.42

0.567

Lysophosphatidylcholine (LPC)

Heart

423.75 ± 35.01

487.00 ± 36.79

0.259

 

Plasma

394.25 ± 13.92

393.00 ± 34.47

0.974

Phosphatidylcholine (PC)

Heart

8091.75 ± 759.67

14169.25 ± 789.30*

0.001

 

Plasma

1246.25 ± 35.92

1130.50 ± 21.52*

0.033

Phosphatidylethanolamine (PE)

Heart

6896.00 ± 624.50

12343.00 ± 434.87*

<0.001

 

Plasma

324.00 ± 23.01

181.75 ± 24.55*

0.006

Phosphatidylserine (PS)

Heart

1321.33 ± 159.17

1614.75 ± 62.90

0.112

 

Plasma

n/a

n/a

 

Triacylglycerol (TAG)

Heart

1038.00 ± 147.45

999.25 ± 360.61

0.924

 

Plasma

1527.50 ± 108.83

331.50 ± 39.01*

<0.001

Free Cholesterol (FC)

Heart

3762.25 ± 327.30

3651.00 ± 151.38

0.768

 

Plasma

632.75 ± 30.51

622.25 ± 22.22

0.790

Data are presented as mean ± SEM. * Significantly different from PD2 rats. N = 4 samples for each experimental group. Note: plasma from 2-3 pups was pooled to generate one sample. N/A = not applicable.

Table 2 summarizes only those alterations that had statistically significant cardiac lipid profiles. PD2 cardiac TAG-20:5n3 was decreased, while PE-14:0, PS-18:2n6, and PS-20:4n6 were increased by exposure to hypoxia. Following recovery from hypoxia, PD2 cardiac DAG-16:0, DAG-18:0, PC-18:2n6, PS-dm16:0, and PC-20:4n6 were increased. Additionally, PS-18:2n6 and PS-20:4n6 remained significantly increased following recovery from hypoxia when compared to baseline. In the hearts of PD60 rats, 16:0, 16:1n7, 18:1n9, 18:3n3, and 18:2n6 in the FFA fraction were increased by exposure to acute hypoxia. There were no significant changes in the PD60 cardiac lipid profile following recovery from hypoxia.
Table 2

Cardiac lipid profiling in PD2 and PD60 rats - effects of hypoxia and recovery.

Lipid Class - Fatty Acid

Baseline

2 h of Hypoxia

2 h Recovery From Hypoxia

PD2 Heart

   

PE - 14:0

18.12 ± 1.94

33.72 ± 3.22 b

25.15 ± 3.88

TAG - 20:5n3

23.40 ± 2.23

13.97 ± 1.50a

18.22 ± 2.15

DAG - 16:0

162.65 ± 14.40

181.48 ± 10.22

215.03 ± 13.13a

DAG - 18:0

73.10 ± 5.66

79.82 ± 4.74

94.55 ± 2.95a

PC - 18:2n6

910.23 ± 51.81

1016.28 ± 43.05

1137.85 ± 37.57b

PC - 20:4n6

3357.63 ± 241.70

3829.30 ± 187.24

4163.98 ± 91.42a

PE - 22:5n3

348.03 ± 31.18

376.00 ± 13.45

445.35 ± 21.60a

PS - 18:2n6

73.93 ± 3.22

84.22 ± 3.55a

88.72 ± 1.69b

PS - 20:4n6

249.07 ± 29.52

317.28 ± 15.47a

368.38 ± 5.09d

PS - dm16:0

29.67 ± 3.93

41.53 ± 3.45

45.65 ± 3.74a

PD60 Heart

   

FFA - 16:0

503.55 ± 32.46

715.00 ± 70.41a

539.00 ± 18.51

FFA - 16:1n7

12.15 ± 0.55

44.85 ± 7.77d

15.00 ± 1.07

FFA - 18:1n9

200.07 ± 15.70

420.65 ± 49.30d

281.20 ± 11.50

FFA - 18:3n3

15.47 ± 1.26

37.97 ± 3.96e

18.77 ± 1.39

FFA - 18:2n6

438.52 ± 39.99

710.65 ± 90.36a

546.32 ± 32.84

FFA (total)

2093.50 ± 153.14

3000.00 ± 303.04a

2375.00 ± 88.179

TAG - 20:4n6

148.50 ± 21.07

324.10 ± 51.47a

182.02 ± 43.99

TAG - 18:1n9

517.25 ± 241.95

2694.30 ± 902.49a

500.62 ± 96.65

TAG (total)

999.25 ± 360.61

3986.00 ± 1295.06a

962.25 ± 163.08

Animals were exposed to hypoxia (8% O2) for 2 h or exposed to hypoxia for 2 h and allowed to recover in room air (21% O2) for an additional 2 h. Due to the size of the data set produced by the lipid profiling analyses, only significant changes (p < 0.05) are shown. Data are presented as mean ± SEM (nmol/g tissue). All comparisons were made versus Baseline as follows: a P < 0.05, b P < 0.02, c P < 0.01, d P < 0.005, and e P < 0.001. Lipid class abbreviations can be found in the legend of Table 1.

Total plasma FFA concentrations, including 16:0, 18:1n9, and 18:2n6, were significantly decreased by exposure to hypoxia in PD2 rats (Table 3); there were no changes following recovery. Plasma total FFA (e.g. 16:0, 16:1n7, 18:1n9, and 18:2n6) was increased by exposure to hypoxia in PD60 rats. Plasma TAG-20:4n6 and LPC-20:4n6 were altered by hypoxia, and these alterations remained following recovery from hypoxia.
Table 3

Plasma lipid profiling in PD2 and PD60 rats - effects of hypoxia and recovery.

Lipid Class - Fatty Acid

Baseline

2 h of Hypoxia

2 h Recovery From Hypoxia

PD2 Plasma

   

FFA - 16:0

173.62 ± 15.61

90.62 ± 5.42e

146.32 ± 7.90

FFA - 18:1n9

80.02 ± 10.08

37.60 ± 2.89d

66.52 ± 3.73

FFA - 18:2n6

104.57 ± 6.31

47.90 ± 5.80e

91.22 ± 3.16

FFA (total)

689.25 ± 53.22

344.50 ± 26.29e

614.75 ± 27.21

PD60 Plasma

   

FFA - 16:0

192.52 ± 10.04

350.65 ± 12.19e

160.42 ± 14.72

FFA - 16:1n7

19.45 ± 1.24

50.07 ± 2.90e

17.00 ± 2.24

FFA - 18:1n9

101.42 ± 5.50

211.85 ± 3.29e

82.70 ± 8.92

FFA - 18:2n6

167.85 ± 3.99

363.10 ± 11.27e

134.65 ± 18.16

FFA (total)

653.00 ± 27.42

1249.00 ± 46.82e

538.00 ± 53.79

TAG - 20:4n6

76.10 ± 8.94

177.45 ± 24.25d

128.22 ± 9.35a

LPC - 20:4n6

54.57 ± 5.55

36.55 ± 5.81a

34.35 ± 1.46a

Animals were exposed to hypoxia (8% O2) for 2 h or exposed to hypoxia for 2 h and allowed to recover in room air (21% O2) for an additional 2 h. Due to the size of the data set produced by the lipid profiling analyses, only significant changes (p < 0.05) are shown. Data are presented as mean ± SEM (nmol/g plasma). All comparisons were made versus Baseline as follows: a P < 0.05, b P < 0.02, c P < 0.01, d P < 0.005, and e P < 0.001. N = 4 samples for each experimental group. Note: plasma from 2-3 PD2 rats was pooled to generate one sample. Lipid class abbreviations can be found in the legend of Table 1.

Cardiac acylcarnities AC4:0, AC5:0, and AC6:0 were decreased during hypoxia in PD2 rats (Figure 1). After recovery, these metabolites returned to baseline, but AC3:0, AC16:0, and AC18:0 were increased. Interestingly, most AC metabolites were increased by exposure to hypoxia in PD60 hearts; these changes returned to baseline values following recovery. Carnitine concentrations were significantly lower in PD2 versus PD60 hearts; however, there was no effect of hypoxia or recovery in either age group.
Figure 1

Effects of exposure to and recovery from acute hypoxia in the PD2 (upper panel) and PD60 (lower panel) rat: cardiac acylcarnitine profiling. Rats were sacrificed at baseline (black bars), 2 h after the onset of hypoxia (light gray bars), or 2 h after return to normoxia (dark gray bars). Acylcarnitine molecular species are listed on the x-axis. N = 4 per time point (within each age group). *Significant difference from baseline by one-way ANOVA (P < 0.05). +Significant difference from baseline and 2 h of hypoxia by one-way ANOVA (P < 0.05).

Plasma AC3:0, AC4:0, AC5:0, and AC6:0 were significantly decreased during hypoxia in PD2 rats (Figure 2). Following recovery, PD2 plasma AC8:0, AC14:0, AC18:1n9, and AC18:n6 were significantly increased. AC4:0, AC14:0, AC16:0, AC18:0, AC18:1n9, and AC18:2n6 were all increased by exposure to hypoxia in PD60 rats. Plasma carnitine concentrations were significantly higher in PD2 rats when compared to PD60 rats (P = 0.017), but hypoxia had no effect at both ages.
Figure 2

Effects of exposure to and recovery from acute hypoxia in the PD2 (upper panel) and PD60 (lower panel) rat: plasma acylcarnitine profiling. Rats were sacrificed at baseline (black bars), 2 h after the onset of hypoxia (light gray bars), or 2 h after return to normoxia (dark gray bars). Acylcarnitine molecular species are listed on the x-axis. N = 4 per time point (within each age group). Plasma samples for PD2 rats were pooled in order to generate one sample (N = 4 pups/sample). *Significant difference from baseline by one-way ANOVA (P < 0.05). +Significant difference from baseline and 2 h of hypoxia by one-way ANOVA (P < 0.05). ND = not detected.

Discussion

This comprehensive survey generated a large data set, yet a limited number of statistically significant changes were identified, demonstrating the specificity of the analysis. We will focus only on a subset of these changes and propose importance for their effects on cardiac function during or after exposure to hypoxia.

Hearts from PD2 rats exhibited resistance to hypoxia-induced changes in the lipid profile. Hypoxia caused a significant decrease in short-chain AC in the PD2 heart. This may have been due to increased mitochondrial β-oxidation under hypoxic conditions, as decreases in AC suggest their disappearance into mitochondria for subsequent metabolism. Conversely, PD2 hearts may have reverted to the oxidation of glucose (i.e. the fetal phenotype) under hypoxic conditions [18].

Following recovery from hypoxia, hearts from PD2 rats showed increases in 18:2n6, 20:4n6, and dm16:0 in the PS fraction. An increase in cardiac PS-associated n6 fatty acids and plasmalogen (i.e. dm16:0) may have altered the fluidity of cellular membranes, affecting membrane-associated signal transduction and intracellular Ca2+ dynamics [19, 20]. AC16:0 and AC18:0 were also increased in PD2 hearts following recovery from hypoxia. These long-chain AC's promote arrhythmogenesis via disruption of ion transport in sarcolemmal membranes and also induce mitochondrial and cellular uncoupling [21, 22], suggesting that the PD2 heart may be at risk for rhythm disturbances following recovery from acute hypoxia.

As opposed to the PD2 heart, the lipid and fatty acid profile of the PD60 heart exhibited many changes in response to acute hypoxia. The FFAs 16:0, 16:1n7, 18:1n9, 18:3n3, and 18:2n6, and all long-chain AC metabolites measured, were increased by hypoxia. Accumulation of long-chain FFA and their AC counterparts have been shown to be detrimental to cardiac function [2224]. Remarkably, following recovery from acute hypoxia, the lipid and fatty acid profiles of the PD60 heart were not different from baseline values.

All major plasma FFA were significantly decreased by exposure to hypoxia in PD2 pups. The disappearance of plasma FFA may have been due to increased insulin concentrations, and could prove beneficial in the response to hypoxia. For example, enhanced FFA utilization for hepatic gluconeogenesis may have been cardioprotective by providing the glucose needed for myocardial ATP generation [25]. Following recovery from hypoxia, the concentrations of AC18:1n9 and AC18:2n6 were significantly elevated. Unsaturated AC metabolites may lead to rhythm disturbances in the heart, as has been shown in myocardial ischemia [26].

Exposure of PD60 rats to hypoxia elicited significant increases in plasma metabolites from most fatty acid families in the FFA fraction. Plasma FFA and long-chain AC accumulation is often found in patients with acute myocardial infarction, and may negatively affect cardiac function through a number of inter- and intracellular mechanisms [15, 21, 22, 24, 27]. Plasma TAG-20:4n6 was increased in PD60 rats exposed to hypoxia and remained increased following recovery, and may cause contractile dysfunction and intracellular calcium overload [28]. Furthermore, increases in plasma lipid and fatty acids coincided with similar elevations of the same lipid metabolites in heart tissue.

The significant changes observed in this robust data set should serve as a basis for further exploration of the effects of acute hypoxia in the developing heart. The study highlighted changes in lipid metabolism that could potentially affect cardiac function, either in a positive or negative manner. These comprehensive analyses should lead investigators to focus on specific pathways relevant to the changes in lipid metabolites we have highlighted.

Declarations

Acknowledgements

The authors wish to thank Barbara Jankowski, Pete Homar, Dr. Matt Tector and Dr. Paul Werner. This study was supported in part by the Kailas and Becky Rao Cardiac Care Fund at Aurora St. Luke's Medical Center.

Authors’ Affiliations

(1)
Endocrine Research Laboratory, Aurora St. Luke's Medical Center
(2)
Department of Medicine, Medical College of Wisconsin

References

  1. Frankel L, Stevenson DK: Metabolic emergencies of the newborn: hypoxemia and hypoglycemia. Compr Ther. 1987, 13: 14-19.PubMedGoogle Scholar
  2. Friedman AH, Fahey JT: The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease. Semin Perinatol. 1993, 17: 106-121.PubMedGoogle Scholar
  3. Knight DB: The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol. 2001, 6: 63-73. 10.1053/siny.2000.0036View ArticlePubMedGoogle Scholar
  4. Yu VY, Knight DB, Obeyesekere HI, Mitvalsky J: The management of patent ductus arteriosus in very low birthweight infants. J Singapore Paediatr Soc. 1983, 25: 159-166.PubMedGoogle Scholar
  5. Bruder ED, Taylor JK, Kamer KJ, Raff H: Development of the ACTH and corticosterone response to acute hypoxia in the neonatal rat. Am J Physiol Regul Integr Comp Physiol. 2008, 295: R1195-R1203.PubMed CentralView ArticlePubMedGoogle Scholar
  6. Kjekshus JK, Ellekjaer E, Rinde P: The effect of free fatty acids on oxygen consumption in man: the free fatty acid hypothesis. Scand J Clin Lab Invest. 1980, 40: 63-70. 10.3109/00365518009091528View ArticlePubMedGoogle Scholar
  7. Pinotti MF, Silva MD, Sugizaki MM, Diniz YS, Sant'ana LS, Aragon FF, Padovani CR, Novelli EL, Cicogna AC: Effect of unsaturated fatty acids on myocardial performance, metabolism and morphology. Braz J Med Biol Res. 2006, 39: 305-312. 10.1590/S0100-879X2006000200019View ArticlePubMedGoogle Scholar
  8. Simopoulos AP: The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr. 2008, 17 (Suppl 1): 131-134.PubMedGoogle Scholar
  9. Lee van der KA, Vork MM, De Vries JE, Willemsen PH, Glatz JF, Reneman RS, van der V, van Bilsen M: Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res. 2000, 41: 41-47.PubMedGoogle Scholar
  10. Vusse Van der GJ, Glatz JF, Stam HC, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev. 1992, 72: 881-940.PubMedGoogle Scholar
  11. Vusse Van der GJ, Van Bilsen M, Glatz JF: Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000, 45: 279-293. 10.1016/S0008-6363(99)00263-1View ArticlePubMedGoogle Scholar
  12. Osmundsen H, Hovik R: Beta-oxidation of polyunsaturated fatty acids. Biochem Soc Trans. 1988, 16: 420-422.View ArticlePubMedGoogle Scholar
  13. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED: Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation. 2005, 112: 2686-2695. 10.1161/CIRCULATIONAHA.105.554360View ArticlePubMedGoogle Scholar
  14. Corr PB, Yamada KA: Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. Herz. 1995, 20: 156-168.PubMedGoogle Scholar
  15. Kim D, Duff RA: Regulation of K+ channels in cardiac myocytes by free fatty acids. Circ Res. 1990, 67: 1040-1046.View ArticlePubMedGoogle Scholar
  16. Stanley WC, Chandler MP: Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 2002, 7: 115-130. 10.1023/A:1015320423577View ArticlePubMedGoogle Scholar
  17. Bruder ED, Lee PC, Raff H: Metabolomic analysis of adrenal lipids during hypoxia in the neonatal rat: implications in steroidogenesis. Am J Physiol Endocrinol Metab. 2004, 286: E697-E703. 10.1152/ajpendo.00502.2003View ArticlePubMedGoogle Scholar
  18. Makinde AO, Kantor PF, Lopaschuk GD: Maturation of fatty acid and carbohydrate metabolism in the newborn heart. Mol Cell Biochem. 1998, 188: 49-56. 10.1023/A:1006860104840View ArticlePubMedGoogle Scholar
  19. Vance JE, Steenbergen R: Metabolism and functions of phosphatidylserine. Prog Lipid Res. 2005, 44: 207-234. 10.1016/j.plipres.2005.05.001View ArticlePubMedGoogle Scholar
  20. Ford DA, Hale CC: Plasmalogen and anionic phospholipid dependence of the cardiac sarcolemmal sodium-calcium exchanger. FEBS Lett. 1996, 394: 99-102. 10.1016/0014-5793(96)00930-1View ArticlePubMedGoogle Scholar
  21. Yamada KA, Kanter EM, Newatia A: Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum. J Cardiovasc Pharmacol. 2000, 36: 14-21. 10.1097/00005344-200007000-00002View ArticlePubMedGoogle Scholar
  22. Yamada KA, McHowat J, Yan GX, Donahue K, Peirick J, Kleber AG, Corr PB: Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. Circ Res. 1994, 74: 83-95.View ArticlePubMedGoogle Scholar
  23. Kjekshus JK, Mjos OD: Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest. 1972, 51: 1767-1776. 10.1172/JCI106978PubMed CentralView ArticlePubMedGoogle Scholar
  24. Wu J, McHowat J, Saffitz JE, Yamada KA, Corr PB: Inhibition of gap junctional conductance by long-chain acylcarnitines and their preferential accumulation in junctional sarcolemma during hypoxia. Circ Res. 1993, 72: 879-889.View ArticlePubMedGoogle Scholar
  25. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res. 1997, 33: 243-257. 10.1016/S0008-6363(96)00245-3View ArticlePubMedGoogle Scholar
  26. Ford DA, Han X, Horner CC, Gross RW: Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool. Biochemistry. 1996, 35: 7903-7909. 10.1021/bi960552nView ArticlePubMedGoogle Scholar
  27. Kang JX, Leaf A: Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci USA. 1996, 93: 3542-3546. 10.1073/pnas.93.8.3542PubMed CentralView ArticlePubMedGoogle Scholar
  28. Burton KP, Buja LM, Sen A, Willerson JT, Chien KR: Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with the loss of contractile function and the development of calcium overload. Am J Pathol. 1986, 124: 238-245.PubMed CentralPubMedGoogle Scholar

Copyright

© Bruder and Raff; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement